These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1800352)

  • 61. Letter: Uses and usefulness of penicillamine.
    Scheinberg IH
    N Engl J Med; 1975 May; 292(20):1080. PubMed ID: 1124096
    [No Abstract]   [Full Text] [Related]  

  • 62. [Penicillamine in the treatment of Wilson's disease. Clinical picture].
    Hauftová D; Hartl J; Seidlová V; Růzicková R; Kubĕna K; Slavícek J
    Vnitr Lek; 1970 Apr; 16(4):337-43. PubMed ID: 5429582
    [No Abstract]   [Full Text] [Related]  

  • 63. [Urine copper determination in Wilson's disease during therapy].
    Schnack H
    Wien Z Inn Med; 1967; 48(12):469-76. PubMed ID: 5620588
    [No Abstract]   [Full Text] [Related]  

  • 64. Toxic reactions to penicillamine in patients with Wilson's disease.
    Walshe JM
    Postgrad Med J; 1968 Oct; ():Suppl:6-8. PubMed ID: 5706614
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
    Haslam RH; Sass-Kortsak A; Stout W; Berg M
    Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Clinical, therapeutic and isotopic study of familial Wilson's disease: desensitization to penicillamine D].
    Mirouze J; Jaffiol C; Mary P
    Mars Med; 1969; 106(6):495-503. PubMed ID: 4246638
    [No Abstract]   [Full Text] [Related]  

  • 67. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
    Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
    Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
    [No Abstract]   [Full Text] [Related]  

  • 68. [Lupoid syndrome due to D-penicillamine associated with Wilson's disease: clinical study of a case].
    Caille B; Harpey JP; Lejeune C; Sudre Y; Turpin R
    Ann Med Interne (Paris); 1971 Feb; 122(2):255-60. PubMed ID: 5579427
    [No Abstract]   [Full Text] [Related]  

  • 69. [The therapeutic use of D-penicyllamine in the light of most recent pharmacokinetic and clinical observations (author's transl)].
    Sarosiek J; Rudy J
    Przegl Lek; 1979; 36(3):337-41. PubMed ID: 451263
    [No Abstract]   [Full Text] [Related]  

  • 70. Penicillamine.
    Caron GA
    Arch Dermatol; 1968 May; 97(5):587-8. PubMed ID: 4869446
    [No Abstract]   [Full Text] [Related]  

  • 71. Hepatolenticular degeneration: the comparative effectiveness of d-penicillamine, potassium sulfide, and diethylditbiocarbamate as decoppering agents.
    Hsia YE; Combs JT; Hook L; Brandt IK
    J Pediatr; 1966 Jun; 68(6):921-6. PubMed ID: 5327103
    [No Abstract]   [Full Text] [Related]  

  • 72. Letter: Peptic ulceration and D-penicillamine.
    Lyle WH
    Lancet; 1974 Aug; 2(7875):285. PubMed ID: 4135704
    [No Abstract]   [Full Text] [Related]  

  • 73. Nephrotic syndrome after treatment with D-penicillamine.
    Felts JH; King JS; Boyce WH
    Lancet; 1968 Jan; 1(7532):53-4. PubMed ID: 4169108
    [No Abstract]   [Full Text] [Related]  

  • 74. Myasthenia syndrome during penicillamine treatment.
    Czlonkowska A
    Br Med J; 1975 Jun; 2(5973):726-7. PubMed ID: 1139195
    [No Abstract]   [Full Text] [Related]  

  • 75. Letter: Mannosidosis and maternal penicillamine therapy.
    Arbisser AI; Scott CI; Howell BR
    Lancet; 1976 Feb; 1(7954):312-3. PubMed ID: 55632
    [No Abstract]   [Full Text] [Related]  

  • 76. D-penicillamine in the therapy of Indian childhood cirrhosis.
    Bhave S; Pandit A
    Indian J Pediatr; 1987; 54(4):587-90. PubMed ID: 3308697
    [No Abstract]   [Full Text] [Related]  

  • 77. Diagnosing Wilson disease.
    Sowa JM
    Ann Intern Med; 1992 Jul; 117(1):91. PubMed ID: 1596055
    [No Abstract]   [Full Text] [Related]  

  • 78. D-penicillamine interferes with S-homocysteinylation and S-cysteinylation of LDL apolipoprotein B.
    Sotgia S; Carru C; Pinna GA; Deiana L; Zinellu A
    J Clin Pharmacol; 2011 Dec; 51(12):1728-32. PubMed ID: 21098689
    [No Abstract]   [Full Text] [Related]  

  • 79. Penicillamine in Indian childhood cirrhosis.
    Barrow L; Tanner MS
    Lancet; 1987 Aug; 2(8557):513-4. PubMed ID: 2887807
    [No Abstract]   [Full Text] [Related]  

  • 80. A clinical study of bone mesenchymal stem cells for the treatment of hepatic fibrosis induced by hepatolenticular degeneration.
    Zhang D
    Genet Mol Res; 2017 Mar; 16(1):. PubMed ID: 28301671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.